Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 25,231 | 27,479 | 28,825 | 26,161 | 24,328 |
| Operating Income | -25,231 | -27,479 | -28,825 | -26,161 | -24,328 |
| Interest Expense | 581 | 513 | 0 | 0 | 0 |
| Other Income | 79 | -426 | -217 | -219 | -309 |
| Pre-tax Income | -25,733 | -28,418 | -29,042 | -26,380 | -24,637 |
| Income Tax | 8 | 67 | -74 | 61 | 5 |
| Net Income Continuous | -25,741 | -28,485 | -28,968 | -26,441 | -24,642 |
| Net Income | $-25,741 | $-28,485 | $-28,968 | $-26,441 | $-24,642 |
| EPS Basic Total Ops | -0.85 | -0.94 | -0.77 | -0.87 | -1.23 |
| EPS Basic Continuous Ops | -0.85 | -0.94 | -0.76 | -0.87 | -1.23 |
| EPS Diluted Total Ops | -0.85 | -0.94 | -0.77 | -0.87 | -1.23 |
| EPS Diluted Continuous Ops | -0.85 | -0.94 | -0.76 | -0.87 | -1.23 |
| EPS Diluted Before Non-Recurring Items | -0.85 | -0.94 | -0.96 | N/A | N/A |
| EBITDA(a) | $-25,172 | $-27,425 | $-28,777 | $-26,114 | $-24,283 |